Study on the treatment of hepatogenic ulcer

[1]	Sun YuanPei, Guo XiaoXia. Clinical effect of probiotics in treatment of liver cirrhosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2018, 34(1): 73-79. doi: 10.3969/j.issn.1001-5256.2018.01.015
[2]	Du YanQin, Wu Jun, Yang DongLiang. Role of liver sinusoidal endothelial cells in the development and progression of liver fibrosis and related therapeutic strategy[J]. Journal of Clinical Hepatology, 2017, 33(3): 438-444. doi: 10.3969/j.issn.1001-5256.2017.03.008
[3]	Ding HuiGuo, Zhang ShiBin, Li Lei, Li Peng, Zhang YueNing, Wang ZhenBiao. Endoscopic diagnosis and treatment of esophageal and gastric varices in patients with liver cirrhosis:from guidelines to clinical practice[J]. Journal of Clinical Hepatology, 2017, 33(3): 454-457. doi: 10.3969/j.issn.1001-5256.2017.03.011
[4]	Zhang Wei, Jia JiDong. Pathogenesis and new therapeutic targets of liver fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 409-412. doi: 10.3969/j.issn.1001-5256.2017.03.001
[5]	Zhao WenShan, You Hong, Zhao XinYan. Advances in treatment of muscle cramp in liver cirrhosis[J]. Journal of Clinical Hepatology, 2017, 33(10): 2001-2003. doi: 10.3969/j.issn.1001-5256.2017.10.033
[6]	Li HuiLi, Lu XueFeng, Li Na. Efficacy of entecavir combined with alprostadil in treatment of hepatitis B-related cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(2): 292-295. doi: 10.3969/j.issn.1001-5256.2016.02.019
[7]	Wang DongDong, Chen Gang, Hu ZongQiang, Li Li. Research advances in mesenchymal stem cells from various sources in treatment of liver fibrosis[J]. Journal of Clinical Hepatology, 2016, 32(3): 597-600. doi: 10.3969/j.issn.1001-5256.2016.03.044
[8]	Han BenLi. Clinical efficacy of entecavir in HBeAg-negative chronic hepatitis B with compensated cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(8): 1525-1528. doi: 10.3969/j.issn.1001-5256.2016.08.018
[9]	Li XiaoLou, Chen MingSheng, Gan QiaoRong, Jiang XiaoYan, Chen Li. Risk factors for antibiotic prophylaxis failure in patients with liver cirrhosis and upper gastrointestinal bleeding[J]. Journal of Clinical Hepatology, 2016, 32(2): 288-291. doi: 10.3969/j.issn.1001-5256.2016.02.018
[10]	Sun YaMeng, You Hong. Advances in staging and treatment of hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1036-1039. doi: 10.3969/j.issn.1001-5256.2016.06.003
[11]	Yang HanZe. Effect of antiviral therapy on long-term prognosis of patients with decompensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1104-1107. doi: 10.3969/j.issn.1001-5256.2016.06.016
[12]	Zhang ChunQing, Li Jing. Individualized treatment of liver cirrhosis and esophageal and gastric varices from the perspective of Baveno Ⅳ[J]. Journal of Clinical Hepatology, 2016, 32(2): 242-244. doi: 10.3969/j.issn.1001-5256.2016.02.008
[13]	Chen Yu, Zhou Li. Research advances in treatment of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(6): 1069-1074. doi: 10.3969/j.issn.1001-5256.2016.06.009
[14]	Zhang QiDi, Lu LunGen. Mechanisms and treatment of cholestasis- induced liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 337-341. doi: 10.3969/j.issn.1001-5256.2015.03.005
[15]	Li Qiang, Huang YuXian, Chen Liang. Present situation of antiviral therapies for HCV-related cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1813-1816. doi: 10.3969/j.issn.1001-5256.2015.11.011
[16]	Nan YueMin, Niu XueMin. Early diagnosis and empiric therapy for cirrhosis associated with infection[J]. Journal of Clinical Hepatology, 2015, 31(3): 349-353. doi: 10.3969/j.issn.1001-5256.2015.03.008
[17]	Xu Ying, Liu Ping, Mu YongPing. Liver stem cell therapy for cirrhosis: advances in cell classification and selection[J]. Journal of Clinical Hepatology, 2015, 31(8): 1360-1364. doi: 10.3969/j.issn.1001-5256.2015.08.047
[18]	Zhang JingWen, Shi YongQuan, Han Ying. Progress in treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 465-468. doi: 10.3969/j.issn.1001-5256.2015.03.037
[19]	Sun YiFeng, Qin YongMei, Mao YongPing. Effects of anti-helicobacter pylori Therapy on the ammonia in patients with liver cirrhyosis[J]. Journal of Clinical Hepatology, 2001, 17(4): 237-238.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2339) PDF downloads(674)

肝源性溃疡的临床治疗

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

肝源性溃疡的临床治疗

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content